iXpressGenes builds and runs the CoreSignals™ Panel — a 22-signal peripheral blood RNA gene-expression panel for longevity, hormone-optimization, IV-therapy, and recovery clinics. We’re veteran-led, an approved VA vendor, a DoD Mentor-Protégé participant under DTRA, and a 2026 Defense Health Agency research awardee alongside the Birmingham VA Health Care System.

601 Genome Way NW · Huntsville, AL 35806
The company was founded on a question worth answering rigorously: can you measure, at the molecular level, how the body is responding — and can you re-measure it after you do something about it? The answer became CSP. Veteran leadership and defense-sector partnerships keep the operational standard where a federal partner expects it.
In March 2026 the Defense Health Agency's Congressionally Directed Medical Research Programs selected iXpressGenes and the Birmingham VA Health Care System for a Toxic Exposures Research Program award, through a two-tier peer and programmatic review of scientific merit. The work applies the same RNA transcriptomic approach behind CSP. Period of performance runs through 2031.
A five-year Cooperative Research and Development Agreement with the Birmingham VA Health Care System, executed in 2025.
iXpressGenes is certified under CLIA to perform high-complexity clinical testing. The certification covers laboratory personnel, quality control, and proficiency testing — the federal standard for operating a clinical lab.
The lab is accredited by the College of American Pathologists, inspected against detailed, discipline-specific checklists on a recurring cycle. It's the credential most compliance teams look for.
Leadership shaped by service and disciplined operational standards.
Cleared to supply federal partners — a compliance benchmark.
Participant in the defense mentor-protégé program under DTRA.
Location
Huntsville, Alabama
The lab, the team, and the freezers are all in one building on Genome Way.